Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease.

International journal of molecular sciences·2023
Same author

Eosinophil Subtypes in Adults with Asthma and Adults with Chronic Obstructive Pulmonary Disease.

American journal of respiratory and critical care medicine·2023
Same author

Somatotypes trajectories during adulthood and their association with COPD phenotypes.

ERJ open research·2020
Same author

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients.

International journal of chronic obstructive pulmonary disease·2020
Same author

Prognostic Validation Using GesEPOC 2017 Severity Criteria.

Archivos de bronconeumologia·2019
Same author

Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case-Control Study with Follow-up.

Archivos de bronconeumologia·2018
Same journal

Advances in Sarcoidosis.

Archivos de bronconeumologia·2026
Same journal

Spanish Clinical Practice Guidelines for the Diagnosis and Management of Alpha-1 Antitrypsin Deficiency: 2026 Update.

Archivos de bronconeumologia·2026
Same journal

Thoracic Sympathectomy for Harlequin Syndrome.

Archivos de bronconeumologia·2026
Same journal

Prognostic Significance of Electrocardiographic Findings in Hemodynamically Stable Patients With Acute Pulmonary Embolism: Insights From the RIETE Registry.

Archivos de bronconeumologia·2026
Same journal

Endothelial and Angiogenic Biomarkers in Obstructive Sleep Apnea: Longitudinal Associations With Continuous Positive Airway Pressure.

Archivos de bronconeumologia·2026
Same journal

Robotic Resection of Ectopic Paratracheal Thymoma: A Case Report.

Archivos de bronconeumologia·2026
See all related articles

Related Experiment Videos

[COPD disease and malnutrition].

Ciro Casanova Macario1, Juan Pablo de Torres Tajes, María Angeles Martín Palmero

  • 1Servicio de Neumología, Unidad de Investigación, Hospital Universitario La Candelaria, Santa Cruz de Tenerife, España. casanovaciro@gmail.com

Archivos De Bronconeumologia
|February 2, 2010
PubMed
Summary
This summary is machine-generated.

Weight loss and malnutrition are common in advanced chronic obstructive pulmonary disease (COPD), indicating worse prognosis. Nutritional interventions combined with exercise show promise for patients with cachexia.

Related Experiment Videos

Area of Science:

  • Pulmonary Medicine
  • Nutritional Science
  • Clinical Research

Context:

  • Advanced chronic obstructive pulmonary disease (COPD) frequently involves weight loss and malnutrition, primarily lean mass loss.
  • These nutritional deficits are linked to phenotypic heterogeneity and a poorer prognosis, independent of lung function (FEV(1)).
  • Established risk thresholds include a body mass index (BMI) < 21 and fat-free mass index (FFMI) < 17 (men) or < 14 (women).

Purpose:

  • To review the current understanding of weight loss and malnutrition in COPD.
  • To discuss the diagnostic criteria, including BMI and FFMI, and the concept of cachexia in COPD patients.
  • To highlight the limitations in current research regarding the natural course of BMI and the mechanisms of malnutrition in COPD.

Summary:

  • Weight loss and malnutrition, particularly lean mass loss, are significant in advanced COPD, correlating with worse outcomes.
  • While FFMI is a reliable indicator, BMI < 21 is recommended for initial screening, with FFMI used for further evaluation in low-weight individuals.
  • Cachexia, the coexistence of low BMI and FFMI, signifies greater nutritional risk.

Impact:

  • Current evidence supports individualized nutritional treatment combined with pulmonary rehabilitation for cachectic COPD patients.
  • The lack of understanding of malnutrition mechanisms hinders therapeutic advancements in COPD management.
  • Further research is needed to elucidate the pathophysiology and explore novel therapeutic options like hormonal and anti-inflammatory agents.